Committee of the Japanese Ministry of Health has recommended approval of Novavax's COVID-19 vaccine. Once fully approved, the national government will purchase 150 million doses of the drug, which will be produced domestically by Takeda Pharmaceutical.
Committee of the Japanese Ministry of Health has recommended approval of Novavax's COVID-19 vaccine. Once fully approved, the national government will purchase 150 million doses of the drug, which will be produced domestically by Takeda Pharmaceutical. 
reuters.com
English (US) 